These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14248608)

  • 21. EXOGENOUS HEPARIN AND THE HEPARIN CO-FACTOR. EXPERIMENTAL AND CLINICAL STUDIES.
    OLSSON P
    Acta Chir Scand Suppl; 1963; 18():SUPPL319:1-37. PubMed ID: 14085709
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THROMBIN INACTIVATION IN NORMAL PLASMA, SERUM AND PLASMA FRACTIONS, AND ITS RELATION TO HEPARIN.
    BLOMBAECK B; BLOMBAECK M; OLSSON P
    Thromb Diath Haemorrh; 1963 Jul; 143():368-86. PubMed ID: 14081260
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
    J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRYOCOAGULOPATHY WITH PRESENCE OF IMMUNOANTITHROMBIN IN THE COURSE OF LUPUS ERYTHEMATOSUS DISSEMINATUS.
    STRUZIK T; HANICKI Z; HAWIGER J; BIERNACKA B
    Acta Med Pol; 1964; 5():61-80. PubMed ID: 14133809
    [No Abstract]   [Full Text] [Related]  

  • 25. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombin III and heparin.
    Barrowcliffe TW; Johnson EA; Thomas D
    Br Med Bull; 1978 May; 34(2):143-50. PubMed ID: 350337
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxide.
    MONKHOUSE FC; FRANCE ES; SEEGERS WH
    Circ Res; 1955 Jul; 3(4):397-402. PubMed ID: 14390722
    [No Abstract]   [Full Text] [Related]  

  • 28. Actions and interactions of antithrombin and heparin.
    Rosenberg RD
    N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
    [No Abstract]   [Full Text] [Related]  

  • 29. THE REACTIONS OF THROMBIN WITH FIBRINOGEN AND PLASMA ANTITHROMBIN.
    KAZAL LA; GRANNIS GF; TOCANTINS LM
    Thromb Diath Haemorrh; 1965 Jun; 13():343-60. PubMed ID: 14347859
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of intravenous infusions of thrombin and heterogenous blood on lymph coagulability].
    Kuznik BI; Mishchenko VP; Budazhabon GV; Tsybikov NN
    Fiziol Zh SSSR Im I M Sechenova; 1976 Oct; 62(10):1460-5. PubMed ID: 1017512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 33. [ON THE EFFECT OF DRUGS ON INTRAVASCULAR CONSUMPTION COAGULOPATHY CAUSED BY SHOCK (WITH A REFERENCE TO THE SANARELLI-SHWARTZMAN PHENOMENON)].
    NIESERT W; SCHNEIDER J
    Z Geburtshilfe Gynakol; 1965 Feb; 163():105-26. PubMed ID: 14346043
    [No Abstract]   [Full Text] [Related]  

  • 34. ANTITHROMBIN III. ITS METABOLISM AND ITS FUNCTION IN BLOOD COAGULATION.
    HENSEN A; LOELIGER EA
    Thromb Diath Haemorrh; 1963; 83():SUPPL1:1-84. PubMed ID: 14098675
    [No Abstract]   [Full Text] [Related]  

  • 35. Behaviour of the antithrombin time after extracorporeal circulation of blood.
    THIES HA
    Thromb Diath Haemorrh; 1960 Jun; 4():400-9. PubMed ID: 13837841
    [No Abstract]   [Full Text] [Related]  

  • 36. Biologic actions of heparin.
    Rosenberg RD
    Semin Hematol; 1977 Oct; 14(4):427-40. PubMed ID: 144323
    [No Abstract]   [Full Text] [Related]  

  • 37. STUDIES ON THE PATHOGENESIS OF THE GENERALIZED SHWARTZMAN REACTION. I. ALTERATIONS IN THE COAGULATION SYSTEM DURING THE GENERALIZED SHWARTZMAN REACTION OF THE PREGNANT RABBIT.
    RODRIGUEZ ERDMANN F
    Thromb Diath Haemorrh; 1964 Dec; 12():452-61. PubMed ID: 14254703
    [No Abstract]   [Full Text] [Related]  

  • 38. [A HEPARIN-TYPE ANTITHROMBIN IN A GAMMA-MYELOMA. CONSIDERATIONS ON SPONTANEOUS ANTICOAGULANTS IN KAHLER'S DISEASE].
    FAVRE-GILLY J; CREYSSEL R; THOUVEREZ JP; REVOL L; CROIZAT P
    Hemostase; 1963; 3():325-33. PubMed ID: 14151020
    [No Abstract]   [Full Text] [Related]  

  • 39. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ON THE IMMUNOLOGIC NATURE OF ANTITHROMBIN IN THE COURSE OF LUPUS ERYTHEMATOSUS DISSEMINATUS.
    HAWIGER J; HANICKI Z; STRUZIK T
    Acta Med Pol; 1964; 5():53-60. PubMed ID: 14133808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.